Enhancing the Potency of the Antimalarial Agent, WEHI‐601, Through Stereoselective Fluorination
ChemMedChem · 2026-05-27 · 21 (10)
DOI: 10.1002/cmdc.70313 ↗At a glance
Journal article in ChemMedChem, published online on 2026-05-22. Written by Ishika Jaitly and 3 co-authors. Institution: School of Chemistry, University of New South Wales (UNSW), Sydney, Australia. Major MEDLINE topics: Antimalarials, Plasmodium falciparum, Peptidomimetics. 26 references.
Abstract (original language)
WEHI‐601 is a statine‐containing peptidomimetic that inhibits the malarial aspartyl protease, plasmepsin V. In this work, stereoselective fluorination is investigated as a strategy for enhancing the potency of WEHI‐601 through conformational bias. Consistent with prediction, a fluorostatine‐containing analogue of WEHI‐601 is found to deliver stronger antimalarial activity than the lead compound, attributable to conformational preorganisation of the FCCO segment within the peptidomimetic backbone. However, the magnitude of the improvement is small, and this is discussed with reference to the hydrogen bonding capability of the vicinal fluoro‐alcohol motif.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Chemistry, University of New South Wales (UNSW), Sydney, Australia.
ORCID profiles: Luke Hunter
Cite
APA
Jaitly, I., Carey, N., Li, J., & Hunter, L. (2026). Enhancing the Potency of the Antimalarial Agent, WEHI‐601, Through Stereoselective Fluorination. ChemMedChem, 21(10). https://doi.org/10.1002/cmdc.70313
Vancouver
Jaitly I, Carey N, Li J, Hunter L. Enhancing the Potency of the Antimalarial Agent, WEHI‐601, Through Stereoselective Fluorination. ChemMedChem. 2026;21(10). doi:10.1002/cmdc.70313
BibTeX
@article{Jaitly2026,
author = {Jaitly, Ishika and Carey, Nathan and Li, Jonathan and Hunter, Luke},
title = {Enhancing the Potency of the Antimalarial Agent, WEHI‐601, Through Stereoselective Fluorination},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {10},
doi = {10.1002/cmdc.70313}
}
EUVIMED